Concepedia

Clare Mudd

CM

Statistics

Publications

3

Citations

50

H-Index

3

Active since

2013

Affiliations

Horizon Discovery (United Kingdom)(Current)

Clare Mudd is an author at Horizon Discovery (United Kingdom) specializing in molecular oncology, cancer cell signaling, and cancer biomarkers.

Publications per year

2013–2017

3

Publications

3

Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies

Edward Coulstock, Jane Sosabowski, Milan Ovečka et al. · PLoS ONE · 2013 · 22 citations · Full text

, , +16

Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent

Emma J. Haagensen, Huw D. Thomas, Clare Mudd et al. · European Journal of Cancer · 2016 · 17 citations

, , +17

A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds

Claire J. Cairney, Lauren S. Godwin, Alan Bilsland et al. · PLoS Genetics · 2017 · 11 citations · Full text

, , +17

1–3 of 3